SH vs. RDY

Last updated Jun 14, 2026

SH (ProShares Short S&P500) is Inverse Equities fund tracking the S&P 500 (-100%), while RDY (Dr. Reddy's Laboratories Limited) is a stock. Over the past 10 years, SH returned -12.83%/yr vs 4.69%/yr for RDY. At a correlation of -0.37, they often move in opposite directions.

Performance

SH vs. RDY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Short S&P500 (SH) and Dr. Reddy's Laboratories Limited (RDY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SH achieves a -6.39% return, which is significantly lower than RDY's -5.27% return. Over the past 10 years, SH has underperformed RDY with an annualized return of -12.83%, while RDY has yielded a comparatively higher 4.69% annualized return.

SH

• 1D: -0.50%
• 1M: 1.30%
• YTD: -6.39%
• 6M: -6.43%
• 1Y: -15.90%
• 3Y*: -11.96%
• 5Y*: -8.68%
• 10Y*: -12.83%

RDY

• 1D: -0.45%
• 1M: -1.41%
• YTD: -5.27%
• 6M: -5.14%
• 1Y: -15.30%
• 3Y*: 5.74%
• 5Y*: -1.12%
• 10Y*: 4.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SH vs. RDY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SH ProShares Short S&P500	-6.39%	-11.35%	-13.52%	-14.80%	18.98%	-24.21%	-25.09%	-22.12%	4.93%	-17.36%
RDY Dr. Reddy's Laboratories Limited	-5.27%	-10.53%	14.13%	36.47%	-19.74%	-7.33%	76.80%	8.45%	0.37%	-16.46%

Correlation

The correlation between SH and RDY is -0.20, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.20
Correlation (3Y) Calculated over the trailing 3-year period	-0.20
Correlation (5Y) Calculated over the trailing 5-year period	-0.27
Correlation (10Y) Calculated over the trailing 10-year period	-0.28
Correlation (All Time) Calculated using the full available price history since Jun 21, 2006	-0.37

The correlation between SH and RDY shifts across timeframes, from -0.37 (all time) to -0.20 (1 year), reflecting how their relationship changes across market environments.

Return for Risk

SH vs. RDY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SH

SH Risk / Return Rank: 1
SH Sharpe Ratio Rank: 0
SH Sortino Ratio Rank: 1
SH Omega Ratio Rank: 1
SH Calmar Ratio Rank: 2
SH Martin Ratio Rank: 1

RDY

RDY Risk / Return Rank: 11
RDY Sharpe Ratio Rank: 11
RDY Sortino Ratio Rank: 13
RDY Omega Ratio Rank: 14
RDY Calmar Ratio Rank: 10
RDY Martin Ratio Rank: 6

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SH vs. RDY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Short S&P500 (SH) and Dr. Reddy's Laboratories Limited (RDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SH	RDY	Difference
Sharpe ratio: Return per unit of total volatility	-1.22	-0.75	-0.47
Sortino ratio: Return per unit of downside risk	-1.75	-0.93	-0.83
Omega ratio: Gain probability vs. loss probability	0.81	0.88	-0.07
Calmar ratio: Return relative to maximum drawdown	-0.82	-0.84	+0.01
Martin ratio: Return relative to average drawdown	-1.47	-1.52	+0.04

SH vs. RDY - Sharpe Ratio Comparison

The current SH Sharpe Ratio is -1.22, which is lower than the RDY Sharpe Ratio of -0.75. The chart below compares the historical Sharpe Ratios of SH and RDY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SH vs. RDY - Drawdown Comparison

The maximum SH drawdown since its inception was -94.66%, which is greater than RDY's maximum drawdown of -60.62%. Use the drawdown chart below to compare losses from any high point for SH and RDY.

Drawdown Indicators

	SH	RDY	Difference
Max Drawdown Largest peak-to-trough decline	-94.66%	-60.62%	-34.04%
Max Drawdown (1Y) Largest decline over 1 year	-18.16%	-20.65%	+2.49%
Max Drawdown (3Y) Largest decline over 3 years	-38.82%	-26.61%	-12.21%
Max Drawdown (5Y) Largest decline over 5 years	-44.53%	-35.25%	-9.28%
Max Drawdown (10Y) Largest decline over 10 years	-76.12%	-47.13%	-28.99%
Current Drawdown Current decline from peak	-94.53%	-20.54%	-73.99%
Average Drawdown Average peak-to-trough decline	-67.75%	-21.92%	-45.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.13%	13.31%	-3.18%

Volatility

SH vs. RDY - Volatility Comparison

The current volatility for ProShares Short S&P500 (SH) is 4.33%, while Dr. Reddy's Laboratories Limited (RDY) has a volatility of 6.24%. This indicates that SH experiences smaller price fluctuations and is considered to be less risky than RDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SH	RDY	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.33%	6.24%	-1.91%
Volatility (6M) Calculated over the trailing 6-month period	9.59%	17.41%	-7.82%
Volatility (1Y) Calculated over the trailing 1-year period	12.28%	23.20%	-10.92%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.91%	23.26%	-6.35%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.04%	26.58%	-8.54%

Dividends

SH vs. RDY - Dividend Comparison

SH's dividend yield for the trailing twelve months is around 4.43%, more than RDY's 0.69% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RDY Dr. Reddy's Laboratories Limited	0.69%	0.65%	0.60%	1.39%	1.48%	1.04%	0.46%	0.71%	0.00%	0.78%	0.62%	0.63%
SH ProShares Short S&P500	4.43%	4.49%	6.20%	5.37%	1.08%	0.00%	0.16%	1.76%	1.01%	0.06%	0.00%	0.00%

Frequently Asked Questions

Can I hold both SH and RDY in my portfolio?

SH and RDY have a correlation of -0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SH or RDY?

RDY has higher volatility (6.24%) compared to SH (4.33%). In terms of maximum drawdown, SH dropped -94.66% vs RDY's -60.62%.

Which has better risk-adjusted returns?

RDY currently has the higher Sharpe Ratio (-0.75 vs -1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.